- Supported exchanges /
- ST /
- COMBI.ST
Combigene AB (COMBI ST) stock market data APIs
CombiGene AB (publ) engages in the development of gene therapy for severe life-altering diseases in Sweden. The company is developing two candidates for severe chronic pain conditions, which are in preclinical studies include COZY01, a peptide treatment; and COZY02, a gene therapy treatment. It is also developing CG01, an adeno-associated virus-based gene therapy targeting epileptic seizures. The company has a collaboration agreement with Danish company Zyneyro to develop a treatment for chronic pain conditions. CombiGene AB (publ) was incorporated in 1990 and is based in Lidingö, Sweden.
Combigene AB Financial Data Overview
| 2.53 | |
| 2.37 | |
| - | |
| 2.99 | |
| 2.62 | |
| 1.27-4.3 | |
| 50 691 K | |
| 19 801 K | |
| 4 294 K | |
| -0.4524 | |
| 1.526 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Combigene AB Fundamental Data is available in our Financial Data APIs
- Net Revenue 4 294 K
- EBITDA -36 745 820
- Earnings Per Share -1.87
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Combigene AB Earnings via APIs
- Latest Release 2024-11-08
- EPS/Forecast NaN
Get Combigene AB End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
